Vident Investment Advisory, LLC Amicus Therapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $101,185 - $131,376	10,304 New	10,304 $103,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $79,638 - $142,146	-12,783 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $18,391 - $29,090	-2,331 Reduced 15.42%	12,783 $121,000
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $148,419 - $188,018	15,114 New	15,114 $175,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $183,915 - $249,149	-21,043 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $183,284 - $225,580	21,043 New	21,043 $203,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.